GeneTex HistoMAX IHC-validated Antibodies

Monday, 11 March, 2024 | Supplied by: Sapphire Bioscience


Immunohistochemistry (IHC) is an indispensable application routinely employed in academic and clinical research as well as in patient care. In addition to the quality of tissue section preparation, the pivotal component determining the reliability of IHC data is the suitability of the antibody used. This can only be assessed through strict and focused reagent validation.

With this in mind, GeneTex has introduced its HistoMAX product line that consists of antibodies specifically vetted for IHC. All of these reagents were extensively evaluated for IHC, utilising formalin-fixed normal and cancer tissue microarrays for good specificity and high performance. Only antibodies that have passed these stringent performance criteria for IHC will be added to the HistoMAX portfolio.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

Biosensis MAP2 antibodies

Biosensis's validated MAP2 antibodies are designed to help users identify MAP2, whether they...

Bio-Rad Laboratories Celselect Slides validated antibodies for rare cell and CTC enumeration

The antibodies are specific to CTC surface markers to enable the sensitive and specific...

Microbiologics UV-BioTAG QC microorganisms for quality control testing

UV-BioTAG, a line of reference strains containing green fluorescent protein (GFP) markers, makes...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd